Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites
- PMID: 18802688
- DOI: 10.1007/s00134-008-1253-y
Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites
Abstract
Objective: To assess the effect of reducing intra-abdominal pressure (IAP) by paracentesis on renal resistive index (RI), hemodynamics and renal function.
Design and setting: Uncontrolled trial in a university gastroenterological intensive care unit.
Patients: Twelve spontaneously breathing cirrhotic patients with hepatorenal syndrome, tense ascites and a clinical indication for paracentesis.
Interventions: Paracentesis and substitution of albumin.
Measurements and results: Hemodynamic variables were assessed by transpulmonary thermodilution, RI was determined by Doppler ultrasound of renal interlobar arteries. After paracentesis and albumin substitution, there was a significant decrease of IAP (20 mmHg (19-22) to 12 mmHg (10-13), systemic vascular resistance index (from 1,243 dyn s/cm(5)/m(2) (1,095-1,745) to 939 dyn s/cm(5)/m(2) (812-1,365); p = 0.005) and RI (from 0.848 (0.810-0.884) to 0.810 (0.780-0.826); p = 0.003). Arterial compliance increased from 1.33 mL/mmHg (0.89-1.74) to 1.71 mL/mmHg (1.21-2.12), pulse pressure index remained unchanged. Creatinine clearance (ClCreat) increased significantly from 5 mL/min (0-28) to 9 mL/min (0-36) (p = 0.018) and urinary output from 12 mL/h (0-49) to 16 mL/h (0-64) (p = 0.043).
Conclusions: In patients with cirrhosis, HRS and tense ascites, IAP may contribute to renal dysfunction. Reduction of IAP following paracentesis and albumin substitution may improve ClCreat, probably by improving renal blood flow as reflected by decreasing RI in Doppler ultrasound.
Similar articles
-
Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.Crit Care. 2008;12(1):R4. doi: 10.1186/cc6765. Epub 2008 Jan 15. Crit Care. 2008. PMID: 18197961 Free PMC article. Clinical Trial.
-
Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.Am J Gastroenterol. 1997 Mar;92(3):394-9. Am J Gastroenterol. 1997. PMID: 9068457
-
Renal and circulatory effects of large volume plasma expansion in patients with hepatorenal syndrome type 1.Ann Hepatol. 2012 Mar-Apr;11(2):232-9. Ann Hepatol. 2012. PMID: 22345341
-
Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.Ann Ital Med Int. 1999 Oct-Dec;14(4):264-84. Ann Ital Med Int. 1999. PMID: 10638019 Review.
-
Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.Can J Gastroenterol Hepatol. 2020 Jun 22;2020:5106958. doi: 10.1155/2020/5106958. eCollection 2020. Can J Gastroenterol Hepatol. 2020. PMID: 32676484 Free PMC article.
Cited by
-
Refractory Ascites: Pathogenesis, Clinical Impact, and Management.Gastroenterol Hepatol (N Y). 2009 Sep;5(9):647-656. Gastroenterol Hepatol (N Y). 2009. PMID: 37967427 Free PMC article.
-
Evaluation of the renal resistive index and pulsatility index in patients with pleural effusion by duplex Doppler ultrasonography.Jpn J Radiol. 2013 Jan;31(1):39-44. doi: 10.1007/s11604-012-0142-z. Epub 2012 Oct 10. Jpn J Radiol. 2013. PMID: 23054887
-
Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial.Hepatol Int. 2019 Nov;13(6):800-813. doi: 10.1007/s12072-019-09986-9. Epub 2019 Sep 20. Hepatol Int. 2019. PMID: 31541422 Clinical Trial.
-
Transcending boundaries: Unleashing the potential of multi-organ point-of-care ultrasound in acute kidney injury.World J Nephrol. 2023 Sep 25;12(4):93-103. doi: 10.5527/wjn.v12.i4.93. World J Nephrol. 2023. PMID: 37766842 Free PMC article. Review.
-
Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.Nat Rev Nephrol. 2020 Mar;16(3):137-155. doi: 10.1038/s41581-019-0218-4. Epub 2019 Nov 13. Nat Rev Nephrol. 2020. PMID: 31723234 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials